Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Using Secondary Data to Evaluate Sex-based Heterogeneity of GLP-1 Agonists and SGLT2 Inhibitors on Cardiovascular-Kidney-Metabolic Health (CKMH) Outcomes in Real-world Settings (DASH-CKMH)

NCT07188545 is registered in ClinicalTrials.gov with Ohio State University as lead sponsor.

NCT NCT07188545
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07188545 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Using Secondary Data to Evaluate Sex-based Heterogeneity of GLP-1 Agonists and SGLT2 Inhibitors on Cardiovascular-Kidney-Metabolic Health (CKMH) Outcomes in Real-world Settings (DASH-CKMH)
Lead sponsor
Ohio State University
Phase
Observational
Overall status
Active, not recruiting
Start date
September 15, 2025
Completion date
June 30, 2029
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular kidney metabolic syndrome